Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors-Reference-Cited by-同舟云学术

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors

Published:2019 Issue: Volume:17 Page:1339-1347
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Heydt Carina,Becher Ann-Kathrin,Wagener-Ryczek Svenja,Ball Markus,Schultheis Anne M.,Schallenberg Simon,Rüsseler Vanessa,Büttner Reinhard,Merkelbach-Bruse Sabine

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference31 articles.

1. Emerging targeted therapies for the treatment of non-small cell lung cancer;Halliday;Current Oncol Rep,2019

2. Precision diagnosis and treatment for advanced non-small-cell lung cancer;Reck;N Engl J Med,2017

3. Clinical implications of genomic discoveries in lung cancer;Swanton;N Engl J Med,2016

4. Organization of the human hepatocyte growth factor-encoding gene;Seki;Gene,1991

5. MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients;Cappuzzo;Ann Oncol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China;Lung Cancer;2024-08

2. MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature;Therapeutic Advances in Medical Oncology;2024-01

3. Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study;Therapeutic Advances in Medical Oncology;2024-01

4. Ngs and Fish for Met Amplification Detection in Egfr Tki Resistant Non-Small Cell Lung Cancer (Nsclc) Patients: A Prospective, Multicenter Study in China;2024

5. Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers;Pathology;2023-12